An indirect comparison of zanubrutinib vs acalabrutinib plus venetoclax in patients with treatment-naive CLLMazyar Shadman, Talha Munir, Keri Yang et al.|Blood Advances|2026Cited by 1
CLL-1029: A Network Meta-Analysis of Efficacy of Zanubrutinib vs Fixed-Duration Acalabrutinib Plus Venetoclax in Treatment-Naïve Chronic Lymphocytic LeukemiaMazyar Shadman, Talha Munir, Keri Yang et al.|Clinical Lymphoma Myeloma & Leukemia|2025Cited by 0